Discover our latest news, updates and press releases

ALBANY, NY – Albany College of Pharmacy and Health Sciences (ACPHS) is pleased to announce that its Stack Family Center for Biopharmaceutical Education and Training (CBET) is partnering with Univercells Technologies, a Belgian-based company, to provide onsite access and training on cutting bioreactor technologies, the scale-X™ hydro and scale-X carbo fixed-bed bioreactors. This partnership will […]

Jumet (Belgium), June 9, 2022 – Exothera S.A., a leading CDMO that specializes in the development and manufacture of viral vectors for vaccines and gene therapies, has developed and is continuing improving the exoREADY platform for accelerated viral vector manufacture. This fully integrated platform will ensure faster, more cost-effective production of viral vector-based therapeutics (for […]

Jumet, Belgium – 15th June 2022 – Exothera SA today announced a collaboration with LogicBio® Therapeutics and Polyplus-transfection® SA. for the development of a highly scalable AAV manufacturing platform with a capacity from 200 L to 2,000 L. Adeno-associated viruses (AAV) are non-enveloped, non-pathogenic viruses largely used as drug delivery vectors for biotherapeutics, like gene […]

Reugny (France) and Lausanne (Switzerland), 15 June 2022 – Partners involved in the international consortium PAT4CGT announced they received a highly competitive EIC Pathfinder grant following a positive evaluation of their project proposal entitled ‘Closed and automated online monitoring towards process control and improved decision making in cell and gene therapy manufacturing. PAT4CGT was recognized […]

Istanbul (Turkey), 6th July 2022 – Vaccizone, a vaccine development company focusing on innovative antigen delivery technology, selected Exothera S.A. to fast-track process development of its SARS CoV 2 vaccine for European clinical trials. Vaccizone has developed and patented a novel method for delivering antigens and bioactive compounds which can increase the stability and shelf […]

Taipei, Taiwan and Nivelles, Belgium – 14 July 2022 – TFBS Bioscience Inc., the leading GMP viral vector contract development and manufacturing organization in the Asia-Pacific region providing the first viral vector manufacturing in Taiwan, is announcing a partnership with Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable viral production. […]

Unizima S.A. (“Unizima”), Campus Biotech Digital initiated by the Immerscio.bio bioproduction training platform (“CBD”) and COGNOS International (“Cognos”) are joining forces to create a groundbreaking workforce development program in biomanufacturing. The parties have developed a joint curriculum that will provide the theoretical and practical basis for successful biologics manufacturing to participants from the global pharmaceutical […]

Brussels, Belgium, August 31, 2022 – Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable production of advanced therapies, is announcing the appointment of Florence Vicaire as Chief Commercial Officer (CCO). In this newly created role, Ms. Vicaire will be responsible for the commercialization and continued expansion of the company’s enabling […]

Nivelles, Belgium, October 5, 2022 – Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, has completed a EUR 2 m expansion of the Nivelles, Belgium site. The critical investment was made to deliver a deeper level of support and supply chain security to biomanufacturers. Nivelles […]

Helsinki, Finland, January 11th, 2023 – Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, today announced it has selected Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO) specialized in gene therapy, vaccines, and oncolytic viruses, to develop a large-scale manufacturing process for clinical development of […]